Clinical trials
Obese clinical trials
Below are recruiting obese clinical trials, each written for real people, not researchers. We’re tracking 1,499 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07150975RecruitingPhase 3
Study comparing new weekly injection vs. Wegovy for weight loss
This trial tests a new weekly injection called GZR18 against the existing drug Wegovy for weight loss in adults who are overweight or obese. It aims to see which is more effective and safe for helping people lose weight and improve related health conditions.
BeijingAges 18 years+ - NCT07153172RecruitingPhase 1
Safety follow-up for people who got INV-347
This study checks on the long-term safety of people who already received the study drug INV-347 in a previous trial. You'll have your blood tested to see how much of the drug is still in your system.
QuébecAges 18 years+ - NCT07163455Recruiting
Time-restricted eating for keeping weight off
This study tests if eating only during certain hours of the day helps people maintain weight loss after a structured program. It may be a good fit if you are overweight or have related health issues and want a simple eating schedule to follow.
Beijing, Beijing MunicipalityAges 18–65 - NCT07171281Recruiting
Timing meals to improve blood sugar and heart health
This study tests whether eating at specific times of day can help control blood sugar and improve heart health in people with prediabetes or type 2 diabetes. It compares two different eating schedules to see which works better.
NuthetalAges 18–75 - NCT07171723RecruitingPhase 1/Phase 2
Study of LEAP2 on eating control during semaglutide treatment
This study looks at how a natural hormone called LEAP2 affects your appetite and eating behavior while you are taking semaglutide (a weight loss medicine). The results might help doctors understand how to make weight loss treatments even better.
HellerupAges 18–65 - NCT07180316Recruiting
Comparing robotic vs. laparoscopic surgery for weight loss revision
This trial compares two types of surgery (robotic and laparoscopic) to see which leads to fewer problems after a second weight-loss operation. It is for people who need to revise their first bariatric surgery to a Roux-en-Y gastric bypass.
LyonAges 18–70 - NCT07180368Recruiting
Managing multiple medications in older adults
This study looks at how to better manage multiple medications in older adults with long-term health conditions. It aims to improve safety and reduce drug-related problems.
Xi'an, ShaanxiAges 65 years+ - NCT07184086RecruitingPhase 1
Weight loss and metabolism study with two medicines
This study tests how two medicines, cagrilintide and semaglutide, affect your metabolism compared to diet alone. It may help you understand how weight loss changes your body's energy use.
Orlando, FloridaAges 18–65 - NCT07187830Recruiting
Semaglutide for belly fat and liver health in kidney disease
This study looks at whether semaglutide (a diabetes medication) affects belly fat and the liver in people who have both type 2 diabetes and chronic kidney disease. It aims to understand if the drug can improve these health markers even in patients with reduced kidney function.
Edmonton, AlbertaAges 18 years+ - NCT07196852Recruiting
Exercise training and redox status study
This trial looks at how exercise training affects your body's natural antioxidant systems. It may be a good fit if you have a higher body mass index but are otherwise healthy and not taking any medications or supplements.
Trikala, KariesAges 30–45 - NCT07199283Recruiting
Preventing future health problems after preeclampsia
This study looks at whether a simple treatment after childbirth can help prevent future health problems for women who had preeclampsia in their first pregnancy. You may be able to join if you are a first-time mom who had preeclampsia, you are 18 or older, and you have a smartphone.
Stockholm, Stockholm CountyAges 18 years+ - NCT07207772Recruiting
Electric lung imaging vs. standard breathing support in weight-loss surgery
This study compares two ways of setting the breathing machine during weight-loss surgery: one guided by electrical impedance tomography (EIT) and the other by standard care. The goal is to see which one helps your lungs work better during and after surgery.
Jinan, ShandongAges 18–65 - NCT07209202Recruiting
Study on Fructose Handling in Obesity
This study looks at how the body handles fructose (a natural sugar) in people with different weights. It may help explain why some people process sugars differently.
Vallejo, CaliforniaAges 20–55 - NCT07215533Recruiting
Exercise trials for teens and young adults at risk for diabetes
This study compares two types of exercise—high-intensity interval training (HIIT) and time-restricted eating (TRE)—to help lower the risk of developing type 2 diabetes in teens and young adults who are overweight or have obesity.
Syracuse, New YorkAges 14–30 - NCT07217756Recruiting
How weight affects braces treatment in teens
This study looks at how having a higher BMI (body mass index) affects treatment with braces during the teenage years. It will compare results between teens with normal weight and those who are overweight to see if there are any differences in how long or how well braces work.
Rochester, New YorkAges 12–18 - NCT07220213Recruiting
Fellowship to better health for Black men
This study tests a program to help Black men improve their heart health. It focuses on lifestyle changes like diet and physical activity.
Birmingham, AlabamaAges 18 years+ - NCT07221279Recruiting
Walking study for weight and heart health in adults
This study tests if a specific number of daily steps can help overweight or obese adults improve body composition and reduce heart disease risk. It's for people who are otherwise healthy but may have high blood pressure or joint pain managed by medication.
Kennesaw, GeorgiaAges 20 years+ - NCT07226947Recruiting
Exercise to prevent muscle loss with GLP-1 medication
This study looks at whether exercise can help prevent muscle loss in people taking GLP-1 medications (like Wegovy, Ozempic, or Mounjaro) for weight loss. It may help you keep your muscles strong while you lose weight.
Boston, MassachusettsAges 18–99 - NCT07229170Recruiting
Taste changes and eating habits on weight loss drugs
This study looks at how GLP-1 medications (like semaglutide/Wegovy or tirzepatide/Mounjaro) change your sense of taste and eating habits while losing weight. If you are 18–60, have obesity, and have been taking one of these drugs for at least 12 weeks, you may qualify.
Roma, ItalyAges 18–60 - NCT07230496RecruitingPhase 1
Testing LAE103 alone or with LAE102 in healthy adults with extra weight
This trial is testing a new drug called LAE103 (and LAE102) in healthy people who are overweight or obese. It aims to see if the drug is safe and how the body processes it.
Brisbane, QueenslandAges 18–75 - NCT07237750Recruiting
Weight loss trial: endoscopy procedure vs lifestyle changes
This study compares a new endoscopic procedure (a stomach tightening treatment done through a tube in your mouth) with a structured diet and exercise program to help with weight loss. It is for Asian adults who have tried and failed to lose weight before.
Beijing, Beijing MunicipalityAges 18–65 - NCT07241533Recruiting
Asiaticoside for overweight and obesity
This study tests whether a natural compound called asiaticoside can help people who are overweight or have obesity. If you are an adult with a body mass index (BMI) between 24 and 45, you may be able to join and see if the treatment helps with weight loss.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07244458Recruiting
Peanuts and GLP-1 Medications Study
This study looks at how adding peanuts to your diet affects nutrition and health in people who are already taking weight-loss medications like Ozempic, Mounjaro, or Wegovy. It aims to see if peanuts can improve your diet quality and help with weight management.
Clevland, OhioAges 18–80 - NCT07244445Recruiting
Pistachios with GLP-1 therapy for weight and nutrition
This study tests whether adding pistachios to your diet can improve nutrition and weight loss while you are already on a GLP-1 medication like Wegovy, Ozempic, or Mounjaro. It is open to adults who have been on the medication for at least three months.
Clevland, OhioAges 18–80
Hear when a new Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obese?
- Yes. Clin2 currently lists 1,499 recruiting obese studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obese trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obese trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.